Sökning: (L773:2168 6157)
> (2008-2009) >
Cost-effectiveness ...
Cost-effectiveness of endarterectomy in patients with asymptomatic carotid artery stenosis in Sweden
-
- Henriksson, Martin (författare)
- Linköpings universitet,Medicinsk teknologiutvärdering,Hälsouniversitetet
-
- Lundgren, Fredrik (författare)
- Linköpings universitet,Avdelningen för kardiovaskulär medicin,Hälsouniversitetet
-
- Carlsson, Per (författare)
- Linköpings universitet,Medicinsk teknologiutvärdering,Hälsouniversitetet
-
(creator_code:org_t)
- 2008-04-16
- 2008
- Engelska.
-
Ingår i: British Journal of Surgery. - Chichester, West Sussex, United Kingdom : John Wiley & Sons. - 0007-1323 .- 1365-2168. ; 95:6, s. 714-720
- Relaterad länk:
-
http://urn.kb.se/res...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Long-term health outcomes and costs are important when deciding whether a strategy of carotid endarterectomy in addition to best medical management should be recommended for patients with asymptomatic carotid artery stenosis. This study investigated the cost-effectiveness of such a strategy compared with a strategy of best medical management alone.Methods: Based on data from the randomized Asymptomatic Carotid Surgery Trial (ACST), a national vascular database and other published sources, expected costs and health outcomes in terms of quality-adjusted life years (QALYs) of both treatment strategies were estimated using decision-analytical modelling. Cost-effectiveness was established for a Swedish setting from a societal perspective.Results: Base-case analysis showed that the incremental cost per QALY of a strategy with carotid endarterectomy for 65- and 75-year-old men (women) was 34 557 (311 133) and 58 930 (779 776) respectively. Sensitivity analyses indicated that the duration of the treatment effect after 5 years of follow-up in the ACST was important for the cost-effectiveness results.Conclusion: Carotid endarterectomy in addition to best medical management can be considered cost-effective in men aged 73 years or less but is less likely to be cost-effective in older men or in women.
Nyckelord
- MEDICINE
- MEDICIN
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas